COVID-19

After COVID-19, we must rethink how we find and produce new drugs

What can the race for a treatment today teach us about preparing for tomorrow? Image: REUTERS/Athit Perawongmetha

André Loesekrug-Pietri
Chairman, Joint European Disruptive Initiative (JEDI)
Thomas Hermans
Programme Manager, JEDI Covid19 GrandChallenge, and Professor, University of Strasbourg
Share:
Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

Have you read?
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19Health and HealthcareGlobal Health
Share:
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

How is the US economy doing after COVID-19?

Felix Richter

February 2, 2023

About Us

Events

Media

Partners & Members

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum